Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Knowledge Synthesis Grant - Priority Announcement: HIV/AIDS

University of Ottawa

$95,500.00

Comparative Effectiveness of New Antiretroviral Therapies for the Treatment of Drug Naïve HIV Infection: A Multiple Treatment Comparison Meta-Analysis

EF 2012-13

Résumé
More than 40 antiretroviral agents have been developed in the past 2 decades. Many improvements in drug development have resulted in reduced numbers of deaths from HIV/AIDS, when these drugs are accessed in a timely and consistent manner. Current guidelines for the developed world recommend the use of a 'backbone' treatment of 2 nucleoside reverse transcriptase inhibitors (NRTIs) plus either a non-nucleoside reverse transcriptase inhibitor (NNRTI), a ritonavir boosted protease inhibitor (PI), or an integrase strand transfer inhibitor (InSTI). To date, no analysis has examined whether the additions of NNRTIs, PIs, or InSTI to the NRTI backbone are similar or whether some drugs exert a safer profile than others. Therefore, we are proposing a multiple treatment comparison (MTC) meta-analysis to compare the relative efficacy and safety of the newer antiretroviral agents when added to NRTIs. Our overall goal is to ensure our findings are translated to the appropriate agencies involved in the development of antiretroviral treatment guidelines.
Programme
Knowledge Synthesis Grant - Priority Announcement: HIV/AIDS
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
277406
Name
Mills Edward J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Health systems / services
Prcname2
Knowledge Synthesis Grant
Projecttitle
Comparative Effectiveness of New Antiretroviral Therapies for the Treatment of Drug Naïve HIV Infection: A Multiple Treatment Comparison Meta-Analysis
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$95,500
Cihrequipment2
$0
Programname2
Knowledge Synthesis Grant - Priority Announcement: HIV/AIDS
Keyworddelim
Antiretroviral Therapy; Hiv; Meta-Analysis; Multiple Treatment Comparison
Abstract
More than 40 antiretroviral agents have been developed in the past 2 decades. Many improvements in drug development have resulted in reduced numbers of deaths from HIV/AIDS, when these drugs are accessed in a timely and consistent manner. Current guidelines for the developed world recommend the use of a 'backbone' treatment of 2 nucleoside reverse transcriptase inhibitors (NRTIs) plus either a non-nucleoside reverse transcriptase inhibitor (NNRTI), a ritonavir boosted protease inhibitor (PI), or an integrase strand transfer inhibitor (InSTI). To date, no analysis has examined whether the additions of NNRTIs, PIs, or InSTI to the NRTI backbone are similar or whether some drugs exert a safer profile than others. Therefore, we are proposing a multiple treatment comparison (MTC) meta-analysis to compare the relative efficacy and safety of the newer antiretroviral agents when added to NRTIs. Our overall goal is to ensure our findings are translated to the appropriate agencies involved in the development of antiretroviral treatment guidelines.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mills, Edward J; Ford, Nathan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $95,500~ $0~